Global Non-invasive Preimplantation Genetic Testing Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Non-invasive Preimplantation Genetic Testing market size was valued at US$ million in 2022. With growing demand in downstream market, the Non-invasive Preimplantation Genetic Testing is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Non-invasive Preimplantation Genetic Testing market. Non-invasive Preimplantation Genetic Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Non-invasive Preimplantation Genetic Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Non-invasive Preimplantation Genetic Testing market.
Non-invasive preimplantation genetic testing (NI-PGT) is a technique used in assisted reproductive technology (ART) to assess the genetic makeup of embryos before they are implanted into the uterus during in vitro fertilization (IVF).
Key Features:
The report on Non-invasive Preimplantation Genetic Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Non-invasive Preimplantation Genetic Testing market. It may include historical data, market segmentation by Type (e.g., Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Non-invasive Preimplantation Genetic Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Non-invasive Preimplantation Genetic Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Non-invasive Preimplantation Genetic Testing industry. This include advancements in Non-invasive Preimplantation Genetic Testing technology, Non-invasive Preimplantation Genetic Testing new entrants, Non-invasive Preimplantation Genetic Testing new investment, and other innovations that are shaping the future of Non-invasive Preimplantation Genetic Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Non-invasive Preimplantation Genetic Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Non-invasive Preimplantation Genetic Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Non-invasive Preimplantation Genetic Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Non-invasive Preimplantation Genetic Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Non-invasive Preimplantation Genetic Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Non-invasive Preimplantation Genetic Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Non-invasive Preimplantation Genetic Testing market.
Market Segmentation:
Non-invasive Preimplantation Genetic Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Non-invasive Preimplantation Genetic Testing market?
What factors are driving Non-invasive Preimplantation Genetic Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-invasive Preimplantation Genetic Testing market opportunities vary by end market size?
How does Non-invasive Preimplantation Genetic Testing break out type, application?
According to our LPI (LP Information) latest study, the global Non-invasive Preimplantation Genetic Testing market size was valued at US$ million in 2022. With growing demand in downstream market, the Non-invasive Preimplantation Genetic Testing is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Non-invasive Preimplantation Genetic Testing market. Non-invasive Preimplantation Genetic Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Non-invasive Preimplantation Genetic Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Non-invasive Preimplantation Genetic Testing market.
Non-invasive preimplantation genetic testing (NI-PGT) is a technique used in assisted reproductive technology (ART) to assess the genetic makeup of embryos before they are implanted into the uterus during in vitro fertilization (IVF).
Key Features:
The report on Non-invasive Preimplantation Genetic Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Non-invasive Preimplantation Genetic Testing market. It may include historical data, market segmentation by Type (e.g., Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Non-invasive Preimplantation Genetic Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Non-invasive Preimplantation Genetic Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Non-invasive Preimplantation Genetic Testing industry. This include advancements in Non-invasive Preimplantation Genetic Testing technology, Non-invasive Preimplantation Genetic Testing new entrants, Non-invasive Preimplantation Genetic Testing new investment, and other innovations that are shaping the future of Non-invasive Preimplantation Genetic Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Non-invasive Preimplantation Genetic Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Non-invasive Preimplantation Genetic Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Non-invasive Preimplantation Genetic Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Non-invasive Preimplantation Genetic Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Non-invasive Preimplantation Genetic Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Non-invasive Preimplantation Genetic Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Non-invasive Preimplantation Genetic Testing market.
Market Segmentation:
Non-invasive Preimplantation Genetic Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Preimplantation Genetic Screening
- Preimplantation Genetic Diagnosis
- Hospitals
- Diagnostic Laboratories
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Illumina
- Thermo Fisher Scientific
- Agilent
- Revvity
- The Cooper Companies
- Abbott
- TAKARA
- QIAGEN
- Vitrolife
- Oxford Nanopore Technologies
- Yikon Genomics
- Shiva Scientific
- Medicover Genetics
- MedGenome
- Fulgent
- INVICTA GENETICS
- Genea Fertility
- Bioarray
- GeneMind Biosciences
- Unimed Biotech
What is the 10-year outlook for the global Non-invasive Preimplantation Genetic Testing market?
What factors are driving Non-invasive Preimplantation Genetic Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-invasive Preimplantation Genetic Testing market opportunities vary by end market size?
How does Non-invasive Preimplantation Genetic Testing break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive Preimplantation Genetic Testing Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Non-invasive Preimplantation Genetic Testing by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Non-invasive Preimplantation Genetic Testing by Country/Region, 2018, 2022 & 2029
2.2 Non-invasive Preimplantation Genetic Testing Segment by Type
2.2.1 Preimplantation Genetic Screening
2.2.2 Preimplantation Genetic Diagnosis
2.3 Non-invasive Preimplantation Genetic Testing Sales by Type
2.3.1 Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2023)
2.3.2 Global Non-invasive Preimplantation Genetic Testing Revenue and Market Share by Type (2018-2023)
2.3.3 Global Non-invasive Preimplantation Genetic Testing Sale Price by Type (2018-2023)
2.4 Non-invasive Preimplantation Genetic Testing Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Laboratories
2.4.3 Other
2.5 Non-invasive Preimplantation Genetic Testing Sales by Application
2.5.1 Global Non-invasive Preimplantation Genetic Testing Sale Market Share by Application (2018-2023)
2.5.2 Global Non-invasive Preimplantation Genetic Testing Revenue and Market Share by Application (2018-2023)
2.5.3 Global Non-invasive Preimplantation Genetic Testing Sale Price by Application (2018-2023)
3 GLOBAL NON-INVASIVE PREIMPLANTATION GENETIC TESTING BY COMPANY
3.1 Global Non-invasive Preimplantation Genetic Testing Breakdown Data by Company
3.1.1 Global Non-invasive Preimplantation Genetic Testing Annual Sales by Company (2018-2023)
3.1.2 Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Company (2018-2023)
3.2 Global Non-invasive Preimplantation Genetic Testing Annual Revenue by Company (2018-2023)
3.2.1 Global Non-invasive Preimplantation Genetic Testing Revenue by Company (2018-2023)
3.2.2 Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Company (2018-2023)
3.3 Global Non-invasive Preimplantation Genetic Testing Sale Price by Company
3.4 Key Manufacturers Non-invasive Preimplantation Genetic Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-invasive Preimplantation Genetic Testing Product Location Distribution
3.4.2 Players Non-invasive Preimplantation Genetic Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NON-INVASIVE PREIMPLANTATION GENETIC TESTING BY GEOGRAPHIC REGION
4.1 World Historic Non-invasive Preimplantation Genetic Testing Market Size by Geographic Region (2018-2023)
4.1.1 Global Non-invasive Preimplantation Genetic Testing Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Non-invasive Preimplantation Genetic Testing Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Non-invasive Preimplantation Genetic Testing Market Size by Country/Region (2018-2023)
4.2.1 Global Non-invasive Preimplantation Genetic Testing Annual Sales by Country/Region (2018-2023)
4.2.2 Global Non-invasive Preimplantation Genetic Testing Annual Revenue by Country/Region (2018-2023)
4.3 Americas Non-invasive Preimplantation Genetic Testing Sales Growth
4.4 APAC Non-invasive Preimplantation Genetic Testing Sales Growth
4.5 Europe Non-invasive Preimplantation Genetic Testing Sales Growth
4.6 Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Growth
5 AMERICAS
5.1 Americas Non-invasive Preimplantation Genetic Testing Sales by Country
5.1.1 Americas Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023)
5.1.2 Americas Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023)
5.2 Americas Non-invasive Preimplantation Genetic Testing Sales by Type
5.3 Americas Non-invasive Preimplantation Genetic Testing Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Preimplantation Genetic Testing Sales by Region
6.1.1 APAC Non-invasive Preimplantation Genetic Testing Sales by Region (2018-2023)
6.1.2 APAC Non-invasive Preimplantation Genetic Testing Revenue by Region (2018-2023)
6.2 APAC Non-invasive Preimplantation Genetic Testing Sales by Type
6.3 APAC Non-invasive Preimplantation Genetic Testing Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-invasive Preimplantation Genetic Testing by Country
7.1.1 Europe Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023)
7.1.2 Europe Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023)
7.2 Europe Non-invasive Preimplantation Genetic Testing Sales by Type
7.3 Europe Non-invasive Preimplantation Genetic Testing Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive Preimplantation Genetic Testing by Country
8.1.1 Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023)
8.1.2 Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023)
8.2 Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Type
8.3 Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-invasive Preimplantation Genetic Testing
10.3 Manufacturing Process Analysis of Non-invasive Preimplantation Genetic Testing
10.4 Industry Chain Structure of Non-invasive Preimplantation Genetic Testing
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-invasive Preimplantation Genetic Testing Distributors
11.3 Non-invasive Preimplantation Genetic Testing Customer
12 WORLD FORECAST REVIEW FOR NON-INVASIVE PREIMPLANTATION GENETIC TESTING BY GEOGRAPHIC REGION
12.1 Global Non-invasive Preimplantation Genetic Testing Market Size Forecast by Region
12.1.1 Global Non-invasive Preimplantation Genetic Testing Forecast by Region (2024-2029)
12.1.2 Global Non-invasive Preimplantation Genetic Testing Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-invasive Preimplantation Genetic Testing Forecast by Type
12.7 Global Non-invasive Preimplantation Genetic Testing Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Illumina
13.1.1 Illumina Company Information
13.1.2 Illumina Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.1.3 Illumina Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Illumina Main Business Overview
13.1.5 Illumina Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Agilent
13.3.1 Agilent Company Information
13.3.2 Agilent Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.3.3 Agilent Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Agilent Main Business Overview
13.3.5 Agilent Latest Developments
13.4 Revvity
13.4.1 Revvity Company Information
13.4.2 Revvity Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.4.3 Revvity Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Revvity Main Business Overview
13.4.5 Revvity Latest Developments
13.5 The Cooper Companies
13.5.1 The Cooper Companies Company Information
13.5.2 The Cooper Companies Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.5.3 The Cooper Companies Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 The Cooper Companies Main Business Overview
13.5.5 The Cooper Companies Latest Developments
13.6 Abbott
13.6.1 Abbott Company Information
13.6.2 Abbott Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.6.3 Abbott Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Abbott Main Business Overview
13.6.5 Abbott Latest Developments
13.7 TAKARA
13.7.1 TAKARA Company Information
13.7.2 TAKARA Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.7.3 TAKARA Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 TAKARA Main Business Overview
13.7.5 TAKARA Latest Developments
13.8 QIAGEN
13.8.1 QIAGEN Company Information
13.8.2 QIAGEN Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.8.3 QIAGEN Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 QIAGEN Main Business Overview
13.8.5 QIAGEN Latest Developments
13.9 Vitrolife
13.9.1 Vitrolife Company Information
13.9.2 Vitrolife Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.9.3 Vitrolife Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Vitrolife Main Business Overview
13.9.5 Vitrolife Latest Developments
13.10 Oxford Nanopore Technologies
13.10.1 Oxford Nanopore Technologies Company Information
13.10.2 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.10.3 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Oxford Nanopore Technologies Main Business Overview
13.10.5 Oxford Nanopore Technologies Latest Developments
13.11 Yikon Genomics
13.11.1 Yikon Genomics Company Information
13.11.2 Yikon Genomics Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.11.3 Yikon Genomics Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Yikon Genomics Main Business Overview
13.11.5 Yikon Genomics Latest Developments
13.12 Shiva Scientific
13.12.1 Shiva Scientific Company Information
13.12.2 Shiva Scientific Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.12.3 Shiva Scientific Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Shiva Scientific Main Business Overview
13.12.5 Shiva Scientific Latest Developments
13.13 Medicover Genetics
13.13.1 Medicover Genetics Company Information
13.13.2 Medicover Genetics Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.13.3 Medicover Genetics Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Medicover Genetics Main Business Overview
13.13.5 Medicover Genetics Latest Developments
13.14 MedGenome
13.14.1 MedGenome Company Information
13.14.2 MedGenome Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.14.3 MedGenome Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 MedGenome Main Business Overview
13.14.5 MedGenome Latest Developments
13.15 Fulgent
13.15.1 Fulgent Company Information
13.15.2 Fulgent Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.15.3 Fulgent Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Fulgent Main Business Overview
13.15.5 Fulgent Latest Developments
13.16 INVICTA GENETICS
13.16.1 INVICTA GENETICS Company Information
13.16.2 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.16.3 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 INVICTA GENETICS Main Business Overview
13.16.5 INVICTA GENETICS Latest Developments
13.17 Genea Fertility
13.17.1 Genea Fertility Company Information
13.17.2 Genea Fertility Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.17.3 Genea Fertility Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Genea Fertility Main Business Overview
13.17.5 Genea Fertility Latest Developments
13.18 Bioarray
13.18.1 Bioarray Company Information
13.18.2 Bioarray Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.18.3 Bioarray Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Bioarray Main Business Overview
13.18.5 Bioarray Latest Developments
13.19 GeneMind Biosciences
13.19.1 GeneMind Biosciences Company Information
13.19.2 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.19.3 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 GeneMind Biosciences Main Business Overview
13.19.5 GeneMind Biosciences Latest Developments
13.20 Unimed Biotech
13.20.1 Unimed Biotech Company Information
13.20.2 Unimed Biotech Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.20.3 Unimed Biotech Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Unimed Biotech Main Business Overview
13.20.5 Unimed Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive Preimplantation Genetic Testing Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Non-invasive Preimplantation Genetic Testing by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Non-invasive Preimplantation Genetic Testing by Country/Region, 2018, 2022 & 2029
2.2 Non-invasive Preimplantation Genetic Testing Segment by Type
2.2.1 Preimplantation Genetic Screening
2.2.2 Preimplantation Genetic Diagnosis
2.3 Non-invasive Preimplantation Genetic Testing Sales by Type
2.3.1 Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2023)
2.3.2 Global Non-invasive Preimplantation Genetic Testing Revenue and Market Share by Type (2018-2023)
2.3.3 Global Non-invasive Preimplantation Genetic Testing Sale Price by Type (2018-2023)
2.4 Non-invasive Preimplantation Genetic Testing Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Laboratories
2.4.3 Other
2.5 Non-invasive Preimplantation Genetic Testing Sales by Application
2.5.1 Global Non-invasive Preimplantation Genetic Testing Sale Market Share by Application (2018-2023)
2.5.2 Global Non-invasive Preimplantation Genetic Testing Revenue and Market Share by Application (2018-2023)
2.5.3 Global Non-invasive Preimplantation Genetic Testing Sale Price by Application (2018-2023)
3 GLOBAL NON-INVASIVE PREIMPLANTATION GENETIC TESTING BY COMPANY
3.1 Global Non-invasive Preimplantation Genetic Testing Breakdown Data by Company
3.1.1 Global Non-invasive Preimplantation Genetic Testing Annual Sales by Company (2018-2023)
3.1.2 Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Company (2018-2023)
3.2 Global Non-invasive Preimplantation Genetic Testing Annual Revenue by Company (2018-2023)
3.2.1 Global Non-invasive Preimplantation Genetic Testing Revenue by Company (2018-2023)
3.2.2 Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Company (2018-2023)
3.3 Global Non-invasive Preimplantation Genetic Testing Sale Price by Company
3.4 Key Manufacturers Non-invasive Preimplantation Genetic Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-invasive Preimplantation Genetic Testing Product Location Distribution
3.4.2 Players Non-invasive Preimplantation Genetic Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NON-INVASIVE PREIMPLANTATION GENETIC TESTING BY GEOGRAPHIC REGION
4.1 World Historic Non-invasive Preimplantation Genetic Testing Market Size by Geographic Region (2018-2023)
4.1.1 Global Non-invasive Preimplantation Genetic Testing Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Non-invasive Preimplantation Genetic Testing Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Non-invasive Preimplantation Genetic Testing Market Size by Country/Region (2018-2023)
4.2.1 Global Non-invasive Preimplantation Genetic Testing Annual Sales by Country/Region (2018-2023)
4.2.2 Global Non-invasive Preimplantation Genetic Testing Annual Revenue by Country/Region (2018-2023)
4.3 Americas Non-invasive Preimplantation Genetic Testing Sales Growth
4.4 APAC Non-invasive Preimplantation Genetic Testing Sales Growth
4.5 Europe Non-invasive Preimplantation Genetic Testing Sales Growth
4.6 Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Growth
5 AMERICAS
5.1 Americas Non-invasive Preimplantation Genetic Testing Sales by Country
5.1.1 Americas Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023)
5.1.2 Americas Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023)
5.2 Americas Non-invasive Preimplantation Genetic Testing Sales by Type
5.3 Americas Non-invasive Preimplantation Genetic Testing Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Preimplantation Genetic Testing Sales by Region
6.1.1 APAC Non-invasive Preimplantation Genetic Testing Sales by Region (2018-2023)
6.1.2 APAC Non-invasive Preimplantation Genetic Testing Revenue by Region (2018-2023)
6.2 APAC Non-invasive Preimplantation Genetic Testing Sales by Type
6.3 APAC Non-invasive Preimplantation Genetic Testing Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-invasive Preimplantation Genetic Testing by Country
7.1.1 Europe Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023)
7.1.2 Europe Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023)
7.2 Europe Non-invasive Preimplantation Genetic Testing Sales by Type
7.3 Europe Non-invasive Preimplantation Genetic Testing Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive Preimplantation Genetic Testing by Country
8.1.1 Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023)
8.1.2 Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023)
8.2 Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Type
8.3 Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-invasive Preimplantation Genetic Testing
10.3 Manufacturing Process Analysis of Non-invasive Preimplantation Genetic Testing
10.4 Industry Chain Structure of Non-invasive Preimplantation Genetic Testing
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-invasive Preimplantation Genetic Testing Distributors
11.3 Non-invasive Preimplantation Genetic Testing Customer
12 WORLD FORECAST REVIEW FOR NON-INVASIVE PREIMPLANTATION GENETIC TESTING BY GEOGRAPHIC REGION
12.1 Global Non-invasive Preimplantation Genetic Testing Market Size Forecast by Region
12.1.1 Global Non-invasive Preimplantation Genetic Testing Forecast by Region (2024-2029)
12.1.2 Global Non-invasive Preimplantation Genetic Testing Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-invasive Preimplantation Genetic Testing Forecast by Type
12.7 Global Non-invasive Preimplantation Genetic Testing Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Illumina
13.1.1 Illumina Company Information
13.1.2 Illumina Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.1.3 Illumina Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Illumina Main Business Overview
13.1.5 Illumina Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Agilent
13.3.1 Agilent Company Information
13.3.2 Agilent Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.3.3 Agilent Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Agilent Main Business Overview
13.3.5 Agilent Latest Developments
13.4 Revvity
13.4.1 Revvity Company Information
13.4.2 Revvity Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.4.3 Revvity Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Revvity Main Business Overview
13.4.5 Revvity Latest Developments
13.5 The Cooper Companies
13.5.1 The Cooper Companies Company Information
13.5.2 The Cooper Companies Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.5.3 The Cooper Companies Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 The Cooper Companies Main Business Overview
13.5.5 The Cooper Companies Latest Developments
13.6 Abbott
13.6.1 Abbott Company Information
13.6.2 Abbott Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.6.3 Abbott Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Abbott Main Business Overview
13.6.5 Abbott Latest Developments
13.7 TAKARA
13.7.1 TAKARA Company Information
13.7.2 TAKARA Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.7.3 TAKARA Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 TAKARA Main Business Overview
13.7.5 TAKARA Latest Developments
13.8 QIAGEN
13.8.1 QIAGEN Company Information
13.8.2 QIAGEN Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.8.3 QIAGEN Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 QIAGEN Main Business Overview
13.8.5 QIAGEN Latest Developments
13.9 Vitrolife
13.9.1 Vitrolife Company Information
13.9.2 Vitrolife Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.9.3 Vitrolife Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Vitrolife Main Business Overview
13.9.5 Vitrolife Latest Developments
13.10 Oxford Nanopore Technologies
13.10.1 Oxford Nanopore Technologies Company Information
13.10.2 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.10.3 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Oxford Nanopore Technologies Main Business Overview
13.10.5 Oxford Nanopore Technologies Latest Developments
13.11 Yikon Genomics
13.11.1 Yikon Genomics Company Information
13.11.2 Yikon Genomics Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.11.3 Yikon Genomics Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Yikon Genomics Main Business Overview
13.11.5 Yikon Genomics Latest Developments
13.12 Shiva Scientific
13.12.1 Shiva Scientific Company Information
13.12.2 Shiva Scientific Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.12.3 Shiva Scientific Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Shiva Scientific Main Business Overview
13.12.5 Shiva Scientific Latest Developments
13.13 Medicover Genetics
13.13.1 Medicover Genetics Company Information
13.13.2 Medicover Genetics Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.13.3 Medicover Genetics Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Medicover Genetics Main Business Overview
13.13.5 Medicover Genetics Latest Developments
13.14 MedGenome
13.14.1 MedGenome Company Information
13.14.2 MedGenome Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.14.3 MedGenome Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 MedGenome Main Business Overview
13.14.5 MedGenome Latest Developments
13.15 Fulgent
13.15.1 Fulgent Company Information
13.15.2 Fulgent Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.15.3 Fulgent Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Fulgent Main Business Overview
13.15.5 Fulgent Latest Developments
13.16 INVICTA GENETICS
13.16.1 INVICTA GENETICS Company Information
13.16.2 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.16.3 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 INVICTA GENETICS Main Business Overview
13.16.5 INVICTA GENETICS Latest Developments
13.17 Genea Fertility
13.17.1 Genea Fertility Company Information
13.17.2 Genea Fertility Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.17.3 Genea Fertility Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Genea Fertility Main Business Overview
13.17.5 Genea Fertility Latest Developments
13.18 Bioarray
13.18.1 Bioarray Company Information
13.18.2 Bioarray Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.18.3 Bioarray Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Bioarray Main Business Overview
13.18.5 Bioarray Latest Developments
13.19 GeneMind Biosciences
13.19.1 GeneMind Biosciences Company Information
13.19.2 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.19.3 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 GeneMind Biosciences Main Business Overview
13.19.5 GeneMind Biosciences Latest Developments
13.20 Unimed Biotech
13.20.1 Unimed Biotech Company Information
13.20.2 Unimed Biotech Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
13.20.3 Unimed Biotech Non-invasive Preimplantation Genetic Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Unimed Biotech Main Business Overview
13.20.5 Unimed Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-invasive Preimplantation Genetic Testing Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Non-invasive Preimplantation Genetic Testing Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Preimplantation Genetic Screening
Table 4. Major Players of Preimplantation Genetic Diagnosis
Table 5. Global Non-invasive Preimplantation Genetic Testing Sales by Type (2018-2023) & (K Units)
Table 6. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2023)
Table 7. Global Non-invasive Preimplantation Genetic Testing Revenue by Type (2018-2023) & ($ million)
Table 8. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Type (2018-2023)
Table 9. Global Non-invasive Preimplantation Genetic Testing Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Non-invasive Preimplantation Genetic Testing Sales by Application (2018-2023) & (K Units)
Table 11. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2018-2023)
Table 12. Global Non-invasive Preimplantation Genetic Testing Revenue by Application (2018-2023)
Table 13. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Application (2018-2023)
Table 14. Global Non-invasive Preimplantation Genetic Testing Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Non-invasive Preimplantation Genetic Testing Sales by Company (2018-2023) & (K Units)
Table 16. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Company (2018-2023)
Table 17. Global Non-invasive Preimplantation Genetic Testing Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Company (2018-2023)
Table 19. Global Non-invasive Preimplantation Genetic Testing Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Non-invasive Preimplantation Genetic Testing Producing Area Distribution and Sales Area
Table 21. Players Non-invasive Preimplantation Genetic Testing Products Offered
Table 22. Non-invasive Preimplantation Genetic Testing Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Non-invasive Preimplantation Genetic Testing Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Non-invasive Preimplantation Genetic Testing Sales Market Share Geographic Region (2018-2023)
Table 27. Global Non-invasive Preimplantation Genetic Testing Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Non-invasive Preimplantation Genetic Testing Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Country/Region (2018-2023)
Table 31. Global Non-invasive Preimplantation Genetic Testing Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023) & (K Units)
Table 34. Americas Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2018-2023)
Table 35. Americas Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2018-2023)
Table 37. Americas Non-invasive Preimplantation Genetic Testing Sales by Type (2018-2023) & (K Units)
Table 38. Americas Non-invasive Preimplantation Genetic Testing Sales by Application (2018-2023) & (K Units)
Table 39. APAC Non-invasive Preimplantation Genetic Testing Sales by Region (2018-2023) & (K Units)
Table 40. APAC Non-invasive Preimplantation Genetic Testing Sales Market Share by Region (2018-2023)
Table 41. APAC Non-invasive Preimplantation Genetic Testing Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Non-invasive Preimplantation Genetic Testing Revenue Market Share by Region (2018-2023)
Table 43. APAC Non-invasive Preimplantation Genetic Testing Sales by Type (2018-2023) & (K Units)
Table 44. APAC Non-invasive Preimplantation Genetic Testing Sales by Application (2018-2023) & (K Units)
Table 45. Europe Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023) & (K Units)
Table 46. Europe Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2018-2023)
Table 47. Europe Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2018-2023)
Table 49. Europe Non-invasive Preimplantation Genetic Testing Sales by Type (2018-2023) & (K Units)
Table 50. Europe Non-invasive Preimplantation Genetic Testing Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Non-invasive Preimplantation Genetic Testing
Table 58. Key Market Challenges & Risks of Non-invasive Preimplantation Genetic Testing
Table 59. Key Industry Trends of Non-invasive Preimplantation Genetic Testing
Table 60. Non-invasive Preimplantation Genetic Testing Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Non-invasive Preimplantation Genetic Testing Distributors List
Table 63. Non-invasive Preimplantation Genetic Testing Customer List
Table 64. Global Non-invasive Preimplantation Genetic Testing Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Non-invasive Preimplantation Genetic Testing Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Non-invasive Preimplantation Genetic Testing Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Non-invasive Preimplantation Genetic Testing Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Non-invasive Preimplantation Genetic Testing Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Non-invasive Preimplantation Genetic Testing Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Non-invasive Preimplantation Genetic Testing Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Non-invasive Preimplantation Genetic Testing Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Non-invasive Preimplantation Genetic Testing Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Non-invasive Preimplantation Genetic Testing Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Non-invasive Preimplantation Genetic Testing Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Non-invasive Preimplantation Genetic Testing Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Illumina Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 79. Illumina Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 80. Illumina Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Illumina Main Business
Table 82. Illumina Latest Developments
Table 83. Thermo Fisher Scientific Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 84. Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 85. Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Thermo Fisher Scientific Main Business
Table 87. Thermo Fisher Scientific Latest Developments
Table 88. Agilent Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 89. Agilent Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 90. Agilent Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Agilent Main Business
Table 92. Agilent Latest Developments
Table 93. Revvity Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 94. Revvity Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 95. Revvity Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Revvity Main Business
Table 97. Revvity Latest Developments
Table 98. The Cooper Companies Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 99. The Cooper Companies Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 100. The Cooper Companies Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. The Cooper Companies Main Business
Table 102. The Cooper Companies Latest Developments
Table 103. Abbott Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 104. Abbott Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 105. Abbott Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Abbott Main Business
Table 107. Abbott Latest Developments
Table 108. TAKARA Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 109. TAKARA Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 110. TAKARA Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. TAKARA Main Business
Table 112. TAKARA Latest Developments
Table 113. QIAGEN Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 114. QIAGEN Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 115. QIAGEN Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. QIAGEN Main Business
Table 117. QIAGEN Latest Developments
Table 118. Vitrolife Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 119. Vitrolife Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 120. Vitrolife Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Vitrolife Main Business
Table 122. Vitrolife Latest Developments
Table 123. Oxford Nanopore Technologies Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 124. Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 125. Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Oxford Nanopore Technologies Main Business
Table 127. Oxford Nanopore Technologies Latest Developments
Table 128. Yikon Genomics Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 129. Yikon Genomics Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 130. Yikon Genomics Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Yikon Genomics Main Business
Table 132. Yikon Genomics Latest Developments
Table 133. Shiva Scientific Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 134. Shiva Scientific Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 135. Shiva Scientific Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Shiva Scientific Main Business
Table 137. Shiva Scientific Latest Developments
Table 138. Medicover Genetics Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 139. Medicover Genetics Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 140. Medicover Genetics Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Medicover Genetics Main Business
Table 142. Medicover Genetics Latest Developments
Table 143. MedGenome Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 144. MedGenome Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 145. MedGenome Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. MedGenome Main Business
Table 147. MedGenome Latest Developments
Table 148. Fulgent Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 149. Fulgent Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 150. Fulgent Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Fulgent Main Business
Table 152. Fulgent Latest Developments
Table 153. INVICTA GENETICS Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 154. INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 155. INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. INVICTA GENETICS Main Business
Table 157. INVICTA GENETICS Latest Developments
Table 158. Genea Fertility Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 159. Genea Fertility Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 160. Genea Fertility Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Genea Fertility Main Business
Table 162. Genea Fertility Latest Developments
Table 163. Bioarray Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 164. Bioarray Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 165. Bioarray Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Bioarray Main Business
Table 167. Bioarray Latest Developments
Table 168. GeneMind Biosciences Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 169. GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 170. GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. GeneMind Biosciences Main Business
Table 172. GeneMind Biosciences Latest Developments
Table 173. Unimed Biotech Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 174. Unimed Biotech Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 175. Unimed Biotech Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Unimed Biotech Main Business
Table 177. Unimed Biotech Latest Developments
Table 1. Non-invasive Preimplantation Genetic Testing Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Non-invasive Preimplantation Genetic Testing Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Preimplantation Genetic Screening
Table 4. Major Players of Preimplantation Genetic Diagnosis
Table 5. Global Non-invasive Preimplantation Genetic Testing Sales by Type (2018-2023) & (K Units)
Table 6. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2023)
Table 7. Global Non-invasive Preimplantation Genetic Testing Revenue by Type (2018-2023) & ($ million)
Table 8. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Type (2018-2023)
Table 9. Global Non-invasive Preimplantation Genetic Testing Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Non-invasive Preimplantation Genetic Testing Sales by Application (2018-2023) & (K Units)
Table 11. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2018-2023)
Table 12. Global Non-invasive Preimplantation Genetic Testing Revenue by Application (2018-2023)
Table 13. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Application (2018-2023)
Table 14. Global Non-invasive Preimplantation Genetic Testing Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Non-invasive Preimplantation Genetic Testing Sales by Company (2018-2023) & (K Units)
Table 16. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Company (2018-2023)
Table 17. Global Non-invasive Preimplantation Genetic Testing Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Company (2018-2023)
Table 19. Global Non-invasive Preimplantation Genetic Testing Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Non-invasive Preimplantation Genetic Testing Producing Area Distribution and Sales Area
Table 21. Players Non-invasive Preimplantation Genetic Testing Products Offered
Table 22. Non-invasive Preimplantation Genetic Testing Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Non-invasive Preimplantation Genetic Testing Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Non-invasive Preimplantation Genetic Testing Sales Market Share Geographic Region (2018-2023)
Table 27. Global Non-invasive Preimplantation Genetic Testing Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Non-invasive Preimplantation Genetic Testing Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Country/Region (2018-2023)
Table 31. Global Non-invasive Preimplantation Genetic Testing Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023) & (K Units)
Table 34. Americas Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2018-2023)
Table 35. Americas Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2018-2023)
Table 37. Americas Non-invasive Preimplantation Genetic Testing Sales by Type (2018-2023) & (K Units)
Table 38. Americas Non-invasive Preimplantation Genetic Testing Sales by Application (2018-2023) & (K Units)
Table 39. APAC Non-invasive Preimplantation Genetic Testing Sales by Region (2018-2023) & (K Units)
Table 40. APAC Non-invasive Preimplantation Genetic Testing Sales Market Share by Region (2018-2023)
Table 41. APAC Non-invasive Preimplantation Genetic Testing Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Non-invasive Preimplantation Genetic Testing Revenue Market Share by Region (2018-2023)
Table 43. APAC Non-invasive Preimplantation Genetic Testing Sales by Type (2018-2023) & (K Units)
Table 44. APAC Non-invasive Preimplantation Genetic Testing Sales by Application (2018-2023) & (K Units)
Table 45. Europe Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023) & (K Units)
Table 46. Europe Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2018-2023)
Table 47. Europe Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2018-2023)
Table 49. Europe Non-invasive Preimplantation Genetic Testing Sales by Type (2018-2023) & (K Units)
Table 50. Europe Non-invasive Preimplantation Genetic Testing Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Non-invasive Preimplantation Genetic Testing
Table 58. Key Market Challenges & Risks of Non-invasive Preimplantation Genetic Testing
Table 59. Key Industry Trends of Non-invasive Preimplantation Genetic Testing
Table 60. Non-invasive Preimplantation Genetic Testing Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Non-invasive Preimplantation Genetic Testing Distributors List
Table 63. Non-invasive Preimplantation Genetic Testing Customer List
Table 64. Global Non-invasive Preimplantation Genetic Testing Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Non-invasive Preimplantation Genetic Testing Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Non-invasive Preimplantation Genetic Testing Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Non-invasive Preimplantation Genetic Testing Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Non-invasive Preimplantation Genetic Testing Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Non-invasive Preimplantation Genetic Testing Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Non-invasive Preimplantation Genetic Testing Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Non-invasive Preimplantation Genetic Testing Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Non-invasive Preimplantation Genetic Testing Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Non-invasive Preimplantation Genetic Testing Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Non-invasive Preimplantation Genetic Testing Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Non-invasive Preimplantation Genetic Testing Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Illumina Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 79. Illumina Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 80. Illumina Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Illumina Main Business
Table 82. Illumina Latest Developments
Table 83. Thermo Fisher Scientific Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 84. Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 85. Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Thermo Fisher Scientific Main Business
Table 87. Thermo Fisher Scientific Latest Developments
Table 88. Agilent Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 89. Agilent Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 90. Agilent Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Agilent Main Business
Table 92. Agilent Latest Developments
Table 93. Revvity Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 94. Revvity Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 95. Revvity Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Revvity Main Business
Table 97. Revvity Latest Developments
Table 98. The Cooper Companies Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 99. The Cooper Companies Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 100. The Cooper Companies Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. The Cooper Companies Main Business
Table 102. The Cooper Companies Latest Developments
Table 103. Abbott Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 104. Abbott Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 105. Abbott Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Abbott Main Business
Table 107. Abbott Latest Developments
Table 108. TAKARA Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 109. TAKARA Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 110. TAKARA Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. TAKARA Main Business
Table 112. TAKARA Latest Developments
Table 113. QIAGEN Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 114. QIAGEN Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 115. QIAGEN Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. QIAGEN Main Business
Table 117. QIAGEN Latest Developments
Table 118. Vitrolife Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 119. Vitrolife Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 120. Vitrolife Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Vitrolife Main Business
Table 122. Vitrolife Latest Developments
Table 123. Oxford Nanopore Technologies Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 124. Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 125. Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Oxford Nanopore Technologies Main Business
Table 127. Oxford Nanopore Technologies Latest Developments
Table 128. Yikon Genomics Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 129. Yikon Genomics Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 130. Yikon Genomics Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Yikon Genomics Main Business
Table 132. Yikon Genomics Latest Developments
Table 133. Shiva Scientific Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 134. Shiva Scientific Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 135. Shiva Scientific Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Shiva Scientific Main Business
Table 137. Shiva Scientific Latest Developments
Table 138. Medicover Genetics Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 139. Medicover Genetics Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 140. Medicover Genetics Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Medicover Genetics Main Business
Table 142. Medicover Genetics Latest Developments
Table 143. MedGenome Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 144. MedGenome Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 145. MedGenome Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. MedGenome Main Business
Table 147. MedGenome Latest Developments
Table 148. Fulgent Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 149. Fulgent Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 150. Fulgent Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Fulgent Main Business
Table 152. Fulgent Latest Developments
Table 153. INVICTA GENETICS Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 154. INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 155. INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. INVICTA GENETICS Main Business
Table 157. INVICTA GENETICS Latest Developments
Table 158. Genea Fertility Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 159. Genea Fertility Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 160. Genea Fertility Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Genea Fertility Main Business
Table 162. Genea Fertility Latest Developments
Table 163. Bioarray Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 164. Bioarray Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 165. Bioarray Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Bioarray Main Business
Table 167. Bioarray Latest Developments
Table 168. GeneMind Biosciences Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 169. GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 170. GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. GeneMind Biosciences Main Business
Table 172. GeneMind Biosciences Latest Developments
Table 173. Unimed Biotech Basic Information, Non-invasive Preimplantation Genetic Testing Manufacturing Base, Sales Area and Its Competitors
Table 174. Unimed Biotech Non-invasive Preimplantation Genetic Testing Product Portfolios and Specifications
Table 175. Unimed Biotech Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Unimed Biotech Main Business
Table 177. Unimed Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Non-invasive Preimplantation Genetic Testing
Figure 2. Non-invasive Preimplantation Genetic Testing Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-invasive Preimplantation Genetic Testing Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Non-invasive Preimplantation Genetic Testing Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Non-invasive Preimplantation Genetic Testing Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Preimplantation Genetic Screening
Figure 10. Product Picture of Preimplantation Genetic Diagnosis
Figure 11. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type in 2022
Figure 12. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Type (2018-2023)
Figure 13. Non-invasive Preimplantation Genetic Testing Consumed in Hospitals
Figure 14. Global Non-invasive Preimplantation Genetic Testing Market: Hospitals (2018-2023) & (K Units)
Figure 15. Non-invasive Preimplantation Genetic Testing Consumed in Diagnostic Laboratories
Figure 16. Global Non-invasive Preimplantation Genetic Testing Market: Diagnostic Laboratories (2018-2023) & (K Units)
Figure 17. Non-invasive Preimplantation Genetic Testing Consumed in Other
Figure 18. Global Non-invasive Preimplantation Genetic Testing Market: Other (2018-2023) & (K Units)
Figure 19. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2022)
Figure 20. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Application in 2022
Figure 21. Non-invasive Preimplantation Genetic Testing Sales Market by Company in 2022 (K Units)
Figure 22. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Company in 2022
Figure 23. Non-invasive Preimplantation Genetic Testing Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Company in 2022
Figure 25. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Non-invasive Preimplantation Genetic Testing Sales 2018-2023 (K Units)
Figure 28. Americas Non-invasive Preimplantation Genetic Testing Revenue 2018-2023 ($ Millions)
Figure 29. APAC Non-invasive Preimplantation Genetic Testing Sales 2018-2023 (K Units)
Figure 30. APAC Non-invasive Preimplantation Genetic Testing Revenue 2018-2023 ($ Millions)
Figure 31. Europe Non-invasive Preimplantation Genetic Testing Sales 2018-2023 (K Units)
Figure 32. Europe Non-invasive Preimplantation Genetic Testing Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue 2018-2023 ($ Millions)
Figure 35. Americas Non-invasive Preimplantation Genetic Testing Sales Market Share by Country in 2022
Figure 36. Americas Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country in 2022
Figure 37. Americas Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2023)
Figure 38. Americas Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2018-2023)
Figure 39. United States Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Non-invasive Preimplantation Genetic Testing Sales Market Share by Region in 2022
Figure 44. APAC Non-invasive Preimplantation Genetic Testing Revenue Market Share by Regions in 2022
Figure 45. APAC Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2023)
Figure 46. APAC Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2018-2023)
Figure 47. China Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Non-invasive Preimplantation Genetic Testing Sales Market Share by Country in 2022
Figure 55. Europe Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country in 2022
Figure 56. Europe Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2023)
Figure 57. Europe Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2018-2023)
Figure 58. Germany Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2018-2023)
Figure 67. Egypt Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Non-invasive Preimplantation Genetic Testing in 2022
Figure 73. Manufacturing Process Analysis of Non-invasive Preimplantation Genetic Testing
Figure 74. Industry Chain Structure of Non-invasive Preimplantation Genetic Testing
Figure 75. Channels of Distribution
Figure 76. Global Non-invasive Preimplantation Genetic Testing Sales Market Forecast by Region (2024-2029)
Figure 77. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Non-invasive Preimplantation Genetic Testing Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Non-invasive Preimplantation Genetic Testing Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Non-invasive Preimplantation Genetic Testing
Figure 2. Non-invasive Preimplantation Genetic Testing Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-invasive Preimplantation Genetic Testing Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Non-invasive Preimplantation Genetic Testing Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Non-invasive Preimplantation Genetic Testing Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Preimplantation Genetic Screening
Figure 10. Product Picture of Preimplantation Genetic Diagnosis
Figure 11. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type in 2022
Figure 12. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Type (2018-2023)
Figure 13. Non-invasive Preimplantation Genetic Testing Consumed in Hospitals
Figure 14. Global Non-invasive Preimplantation Genetic Testing Market: Hospitals (2018-2023) & (K Units)
Figure 15. Non-invasive Preimplantation Genetic Testing Consumed in Diagnostic Laboratories
Figure 16. Global Non-invasive Preimplantation Genetic Testing Market: Diagnostic Laboratories (2018-2023) & (K Units)
Figure 17. Non-invasive Preimplantation Genetic Testing Consumed in Other
Figure 18. Global Non-invasive Preimplantation Genetic Testing Market: Other (2018-2023) & (K Units)
Figure 19. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2022)
Figure 20. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Application in 2022
Figure 21. Non-invasive Preimplantation Genetic Testing Sales Market by Company in 2022 (K Units)
Figure 22. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Company in 2022
Figure 23. Non-invasive Preimplantation Genetic Testing Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Company in 2022
Figure 25. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Non-invasive Preimplantation Genetic Testing Sales 2018-2023 (K Units)
Figure 28. Americas Non-invasive Preimplantation Genetic Testing Revenue 2018-2023 ($ Millions)
Figure 29. APAC Non-invasive Preimplantation Genetic Testing Sales 2018-2023 (K Units)
Figure 30. APAC Non-invasive Preimplantation Genetic Testing Revenue 2018-2023 ($ Millions)
Figure 31. Europe Non-invasive Preimplantation Genetic Testing Sales 2018-2023 (K Units)
Figure 32. Europe Non-invasive Preimplantation Genetic Testing Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue 2018-2023 ($ Millions)
Figure 35. Americas Non-invasive Preimplantation Genetic Testing Sales Market Share by Country in 2022
Figure 36. Americas Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country in 2022
Figure 37. Americas Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2023)
Figure 38. Americas Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2018-2023)
Figure 39. United States Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Non-invasive Preimplantation Genetic Testing Sales Market Share by Region in 2022
Figure 44. APAC Non-invasive Preimplantation Genetic Testing Revenue Market Share by Regions in 2022
Figure 45. APAC Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2023)
Figure 46. APAC Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2018-2023)
Figure 47. China Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Non-invasive Preimplantation Genetic Testing Sales Market Share by Country in 2022
Figure 55. Europe Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country in 2022
Figure 56. Europe Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2023)
Figure 57. Europe Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2018-2023)
Figure 58. Germany Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2018-2023)
Figure 67. Egypt Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Non-invasive Preimplantation Genetic Testing Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Non-invasive Preimplantation Genetic Testing in 2022
Figure 73. Manufacturing Process Analysis of Non-invasive Preimplantation Genetic Testing
Figure 74. Industry Chain Structure of Non-invasive Preimplantation Genetic Testing
Figure 75. Channels of Distribution
Figure 76. Global Non-invasive Preimplantation Genetic Testing Sales Market Forecast by Region (2024-2029)
Figure 77. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Non-invasive Preimplantation Genetic Testing Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Non-invasive Preimplantation Genetic Testing Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share Forecast by Application (2024-2029)
